Archive for Medication updates

Source: DHSC 1.9.25 The government will remove red tape, allowing doctors and pharmacists to prescribe flu medicines year-round to reduce winter pressures and protect the NHS. Rule change will allow...

By Dispex Following the publication of the September Drug Tariff a Redetermination notice was published which give the Basic price of Mounjaro for prescription submitted form the end of September...

By Dispex The Category M price of Dapagliflozin 10mg for September is £30.15 (after clawback- £26.83). The best generic acquisition cost as of 12th September (using e-CASS) is £10.80. So...

Source: Community Pharmacy England 29.8.25 From 1 September 2025,  Dydrogesterone 10mg tablets (Nalvee®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has...

Source: NICE 10th June 2025 Updated guideline to increase access to treatments for early-stage chronic heart failure could reduce deaths and hospital admissions by thousands. Around 3,000 deaths and 5,500...

Second Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.

From 1 April the reimbursement price of Inclisiran will increase to £60.00. In addition, the DHSC has classified that all drugs from Part VIIIC – Arrangements of Payment for Products...

 Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.

Name of SSP \ ref no. Start and end date Supporting guidance SSP081 Estradot® 100 microgram patches (PDF:215KB) 19 December 2024 to 04 April 2025 This SSP was amended on 14...

Final Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.

Third Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.